Newsletter | May 12, 2022

05.12.22 -- Celltrion's Remsima Wins Brazilian Tender
 
New Podcast Episode
Featured Editorial
Boosting Pipeline Acceleration With A Strategic Pharma/CDMO Relationship
 
By Ralph Lambalot, Ph.D., independent consultant

Pharma portfolio managers and CDMOs should seek more strategic modes of working together. By coordinating with each other to change all your development and capacity "red lights" to green, and balancing operational efficiency and flexibility, you can accelerate your pipeline. Here's how.
Tips For Making Better Tech Decisions In Biotech Manufacturing
 
By Avril Vermunt, EQRx

As startup pharmas, biotechs, and gene therapy companies, how do we strike the right balance between new technology ROI and its impact on P&L? This article discusses considerations and tips for adopting single-use technologies and deciding when to go digital.
Industry Insights
Is Your Biologic At Risk For Protein Aggregation? Part 2
Article | By Martin Gonzalez, Ph.D., Pfizer CentreOne

The manufacture of sterile injectables is fraught with risk, especially when it comes to protein aggregation in biologic drugs. We offer steps you can take to help prevent aggregation.
How To Use QbD Software To Improve An Existing Identification Method
Article | Pfizer CentreOne

What can you do when the identification method defined by the USP monograph does not provide clear guidance? The authors decided to improve the method with a Quality by Design (QbD) approach.
How Shorter Needles With Thinner Walls Are Set To Improve The Injection Experience In Chronic Care
Q&A | BD Medical - Pharmaceutical Systems

This series of frequently asked questions covers the research and design mindset applied to the development of the BD Neopak™ XtraFlow™ solution and how the anticipated clinical benefits of 8 mm needles will support their broad adoption over time for subcutaneous drug delivery, particularly for use in chronic care settings.
Find The Right Intensification Strategy For Your Upstream And Downstream Processes
Webinar | Cytiva

How do you know if an intensification approach will provide advantages? Three process intensification experts show how different intensification approaches affect outputs using different scenarios.
Sponsor
News Headlines
Solutions
Biotherapy Characterization: Binding Assays
MilliporeSigma (Product Characterization)
Minimizing Uncertainty Throughout The Development Life Cycle
West Pharmaceutical Services, Inc.
Life Science Leader Magazine
 

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.